Stay updated on Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial
Sign up to get notified when there's something new on the Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial page.

Latest updates to the Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated: v3.4.2 added; v3.4.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no substantive changes to study details or page interactions are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. This appears to be a backend/versioning update that does not alter study information or navigation.SummaryDifference0.1%

- Check62 days agoChange DetectedLocations were updated: New Hampshire, New York, Tennessee, Texas, and Victoria were added and prior location entries removed; the HHS Vulnerability Disclosure link was removed (Revision: v3.3.3).SummaryDifference0.7%

- Check91 days agoChange DetectedAdded a clarifying note that publications are automatically filled from PubMed and may not be about the study. Updated the revision label to v3.3.2.SummaryDifference0.1%

- Check99 days agoChange DetectedDeleted the government-funding/operating-status notice from the page; the administrative alert about updates and operating status is no longer displayed.SummaryDifference0.4%

Stay in the know with updates to Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial page.